Skip to main content
Back to News
🌐 Macrocpi Bearish

Tariffs, CPI, and the Next Macro Shock: Why January’s Data Could Rattle Global Markets

Strykr AI
··8 min read
Tariffs, CPI, and the Next Macro Shock: Why January’s Data Could Rattle Global Markets
43
Score
78
High
High
Risk

Strykr Analysis

Bearish

Strykr Pulse 43/100. Market is complacent ahead of a high-risk CPI print. Tariffs could push inflation higher, forcing a hawkish Fed pivot. Threat Level 4/5.

If you’re looking for a market that’s sleepwalking toward a punch in the face, look no further than the global macro complex ahead of January’s CPI print. The full effects of the latest round of tariffs are about to show up in the data, and the market’s collective yawn is the real story. Traders are pricing in a soft landing, but the setup is more like a banana peel on a marble floor. The risk? A CPI shock that exposes just how fragile the current narrative really is.

Let’s start with the facts. The US slapped fresh tariffs on a range of Chinese imports in late 2025, a move that was supposed to be “targeted” but has already rippled through global supply chains. According to Seeking Alpha, the January CPI report will be the first to fully reflect these new costs. Meanwhile, the market is pricing in a Goldilocks scenario, moderate inflation, resilient growth, and a Fed that can thread the needle. But the data doesn’t care about narratives. If tariffs push input costs higher, CPI could surprise to the upside, forcing the Fed’s hand and sending risk assets into a tailspin.

The timeline is tight. The tariffs took effect in December, and supply chain bottlenecks have already started to bite. Shipping rates from Asia to the US are up +18% month-on-month, according to Freightos. Retailers are warning of higher prices, and early earnings calls are littered with references to “input cost inflation.” The bond market, for its part, is starting to sniff out trouble. The US 10-year yield has crept back above 4.25%, and breakeven inflation rates are ticking higher. But equities? They’re blissfully ignoring the risk, with the S&P 500 grinding sideways and volatility near multi-year lows.

The bigger picture is even more precarious. The Fed is stuck between a rock and a hard place. Outgoing Atlanta Fed President Raphael Bostic told Bloomberg that it’s “paramount” for the Fed to get inflation back to its 2% target, but the market is still pricing in rate cuts for late 2026. If the January CPI print comes in hot, those cuts will be priced out faster than you can say “dot plot.” The result? A sharp repricing in rates, a spike in volatility, and a potential correction in risk assets.

What’s absurd is how little the market seems to care. Wall Street strategists are still talking up the “K-shaped economy,” where tech and old-economy stocks can both win. But the reality is that tariffs are a blunt instrument, and their effects are neither targeted nor benign. The last time we saw a tariff shock, think 2018, the market shrugged it off for months, only to panic when the data finally caught up. The setup now is eerily similar. The CPI print is the canary in the coal mine, and the market is holding its breath.

Cross-asset correlations are starting to fray. Commodities are stuck in a holding pattern, with the DBC ETF flatlining at $24.005. Tech stocks are treading water, with XLK pinned at $141.06. The bond market is the only asset class that seems to care, and that’s usually a bad sign for equities. If inflation surprises to the upside, expect a violent rotation out of duration and into cash. The risk is that the move is not orderly but chaotic, as algos scramble to reprice risk in real time.

Strykr Watch

The technicals are sending mixed signals. DBC is stuck at $24.005, with no clear trend. XLK is pinned at $141.06, but momentum is waning. The real action is in rates, with the US 10-year yield above 4.25% and threatening to break higher. Watch for a spike above 4.50% as a trigger for broader risk-off. On the macro calendar, the January CPI print is the main event, with consensus expecting a +0.3% month-on-month increase. A print above +0.4% would be a shock, while a print below +0.2% would be a green light for risk-on. The risk is asymmetric, there’s more downside if inflation surprises to the upside than upside if it comes in soft.

The bear case is simple: tariffs push CPI higher, the Fed pivots hawkish, and risk assets correct. The bull case? Inflation stays contained, the Fed stays dovish, and the market grinds higher. But the odds are skewed. The market is not priced for a CPI shock, and the risk is that traders are caught offsides.

For traders, the opportunity is in playing the event risk. Shorting DBC into a hot CPI print makes sense, as does fading tech strength if rates spike. On the long side, a soft CPI print could spark a relief rally in duration and risk assets. But don’t overstay your welcome, volatility is likely to spike, and the market could whipsaw in both directions.

Strykr Take

The market is underpricing the risk of a tariff-driven CPI shock. The setup is classic: complacency, event risk, and asymmetric downside. Traders should be positioned for volatility, not trend. Watch the data, trade the reaction, and don’t get caught flat-footed when the narrative shifts.

Sources (5)

NYSE's Reinking Weighs in on AI Trade Concerns

It's interesting that the S&P 500 Equal Weight (SPXEW) hit a new all-time high yesterday, posits Michael Reinking. He adds that concerns around AI spe

youtube.com·Feb 7

The Full Effects Of Tariffs To Start Showing Up In January CPI Report

The Full Effects Of Tariffs To Start Showing Up In January CPI Report

seekingalpha.com·Feb 7

Wall Street's wild week rattles investors' confidence while highlighting a growing divide within markets

“It seems like there are two different markets right now,” one strategist says.

marketwatch.com·Feb 7

From AI Darlings To Dow Dinosaurs: Investors Flee Software For Old-Economy Stocks

Software and other AI-exposed stocks have stumbled out of the gate this year, with the sell-off picking up pace in February as fresh fears emerged tha

benzinga.com·Feb 7

Big Pharma's Earnings Week: Strong Performance, Obesity Wars, LOE Management And More

Big Pharma delivered strong Q4 2025 results, with most companies beating revenue and EPS expectations and providing generally solid 2026 guidance. Eli

seekingalpha.com·Feb 7
#cpi#tariffs#inflation#fed#macro-risk#equities#commodities#rates
Get Real-Time Alerts

Related Articles

Tariffs, CPI, and the Next Macro Shock: Why January’s Data Could Rattle Global Markets | Strykr | Strykr